![](/img/cover-not-exists.png)
618PUpdated survival analysis of the randomized phase III trial comparing S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (SALTO) by the Dutch colorectal cancer group
Kwakman, J J, Werkhoven, E Van, Simkens, L H, van Rooijen, J M, van de Wouw, A, Tije, A J Ten, Creemers, G-J, Hendriks, M P, Los, M, van Alphen, R, Polee, M B, Muller, E W, der Velden, A Van, VoorthuiVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz246.095
Date:
October, 2019
File:
PDF, 83 KB
2019